VM
VMD
VMD Viemed Healthcare (VMD) Q2 FY26 earnings call
Viemed Healthcare delivered record Q2 FY26 revenue driven by strong organic growth across its ventilator, sleep therapy, and maternal health segments. The company successfully adapted to new CMS National Coverage Determination requirements, achieving its highest-ever active ventilator patient count. While profitability was impacted by revenue mix and strategic investments in scaling operations, management remains confident in its diversified growth strategy and financial capacity for continued investment.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.